Expert drug‑product formulation, analytics and data‑science support to de‑risk development and accelerate CMC timelines.

Specialised formulation know-how across vaccines & viral vectors, biologics & biosimilars, and bio-functionalized devices.

AI‑guided, DoE‑driven workflow that screens a 100‑excipient library to arrive at optimal formulations in weeks, not months.

Integrated bioinformatics, biostatistics and modelling tools that shift experiments from in‑vitro to in‑silico and predict long‑term stability.